Analysis of the Potentially Parasitocidal Effect of a Long Term Chemotherapy With Benzimidazoles - Full Text View

Analysis of the Potentially Parasitocidal Effect of a Long Term Chemotherapy With Benzimidazoles

This study is currently recruiting participants.
Verified by University of Zurich, April 2008

Sponsored by:	University of Zurich
Information provided by:	University of Zurich
ClinicalTrials.gov Identifier:	NCT00658294

Purpose

The aim of this study is to evaluate PET-CT and EmII/3-10 serology as potential markers to assess the parasitocidal effect of benzimidazoles

Trial with medicinal product

Condition	Intervention	Phase
Alveolar Echinococcosis	Other: Stop treatment	Phase IV

U.S. FDA Resources

Study Type:	Observational
Study Design:	Cohort, Prospective

Official Title:	Analysis of the Potentially Parasitocidal Effect of a Long Term Chemotherapy With Benzimidazoles in Patients With Inoperable Alveolar Echinococcosis Using PET-CT and EmII/3-10 Serology

Further study details as provided by University of Zurich:

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	30
Study Start Date:	January 2008
Estimated Study Completion Date:	January 2009

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Study Population

Patients with inoperable alveolar echinococchosis

Criteria

Inclusion criteria:

Patients with inoperable alveolar echinococcosis
With negative PET-CT
EmII/3-10 serology under long-term chemotherapy with benzimidazoles

Exclusion criteria:

Positive PET-CT
Positive EmII-3-10 Serology
No compliance
Reduced life expectancy
Pregnancy

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00658294

Contacts


Contact: 01 Studienregister MasterAdmins	41-044-255-1111

Locations


Switzerland
	University Hospital Zurich	Recruiting
	Zurich, Switzerland
	Contact Beat.Müllhaupt@usz.ch
	Contact Beat.Müllhaupt@usz.ch

Sponsors and Collaborators

University of Zurich

Investigators


Principal Investigator:	Beat Müllhaupt 01 Studienregister MasterAdmins	UniversitaetsSpital Zuerich

More Information

Responsible Party:	University Hospital Zurich ( Beat Müllhaupt )
Study ID Numbers:	EK-1351
First Received:	April 8, 2008
Last Updated:	April 11, 2008
ClinicalTrials.gov Identifier:	NCT00658294
Health Authority:	Switzerland: Swissmedic

Study placed in the following topic categories:

Hydatidosis

Alveolar echinococcosis

Parasitic Diseases

Benzimidazole

Helminthiasis

Echinococcosis

Additional relevant MeSH terms:

Anti-Infective Agents

Antiparasitic Agents

Therapeutic Uses

Anthelmintics

Cestode Infections

Pharmacologic Actions

ClinicalTrials.gov processed this record on August 20, 2008